missing translation for 'onlineSavingsMsg'
Learn More
Learn More
HLA DQ/DR/DP, Rabbit anti-Human, Clone: HLA-Pan/2967R, Novus Biologicals™
Rabbit Monoclonal Antibody
Brand: Novus Biologicals NBP2-79709-100UG
This item is not returnable.
View return policy
Description
HLA DQ/DR/DP Monoclonal specifically detects HLA DQ/DR/DP in Human samples. It is validated for Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Protein Array.
Specifications
| HLA DQ/DR/DP | |
| Monoclonal | |
| 0.2 mg/mL | |
| Western Blot 1-2 ug/ml, Flow Cytometry 1-2 ug/million cells, ELISA 2-5 ug/ml, Immunohistochemistry 1-2 ug/ml, Immunocytochemistry/Immunofluorescence 1-2 ug/ml, Immunohistochemistry-Paraffin 1-2 ug/ml, Protein Array | |
| P04440, P01908, P01909, P01920, P01903, P01903 | |
| HLA-DQA1 | |
| Non-T, non-B human acute lymphoblastic leukemia REH6 cell line | |
| 100 μg | |
| Adaptive Immunity, Asthma, Diabetes Research, Immunology | |
| 3117 | |
| Human | |
| Purified |
| Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunohistochemistry (Paraffin) | |
| HLA-Pan/2967R | |
| Unconjugated | |
| 10 mM PBS with 0.05% BSA | |
| CD, CELIAC1DQ alpha 1 chain, DC-1 alpha chain, DQ-A1, FLJ27088, FLJ27328, GSE, HLA class II histocompatibility antigen, DQ(W3) alpha chain, HLA-DCA, HLA-DQA, leucocyte antigen DQA1, leukocyte antigen alpha chain, major histocompatibility complex, class II, DQ alpha 1, MGC149527, MHC class II antigen, MHC class II DQA1, MHC class II HLA-D alpha glycoprotein, MHC class II HLA-DQ-alpha-1, MHC class II surface glycoprotein, MHC HLA-DQ alpha | |
| Rabbit | |
| Protein A or G purified | |
| RUO | |
| Primary | |
| This antibody reacts with a common epitope of human major histocompatibility (MHC) class II antigens, HLA DQ/DR/DP. | |
| Store at 4°C. | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction